1. Home
  2. CAN vs LXRX Comparison

CAN vs LXRX Comparison

Compare CAN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • LXRX
  • Stock Information
  • Founded
  • CAN 2013
  • LXRX 1995
  • Country
  • CAN Singapore
  • LXRX United States
  • Employees
  • CAN N/A
  • LXRX N/A
  • Industry
  • CAN Semiconductors
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • LXRX Health Care
  • Exchange
  • CAN Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • CAN 330.5M
  • LXRX 392.2M
  • IPO Year
  • CAN 2019
  • LXRX 2000
  • Fundamental
  • Price
  • CAN $0.66
  • LXRX $1.07
  • Analyst Decision
  • CAN Strong Buy
  • LXRX Buy
  • Analyst Count
  • CAN 6
  • LXRX 4
  • Target Price
  • CAN $2.67
  • LXRX $3.67
  • AVG Volume (30 Days)
  • CAN 58.1M
  • LXRX 3.5M
  • Earning Date
  • CAN 08-14-2025
  • LXRX 08-06-2025
  • Dividend Yield
  • CAN N/A
  • LXRX N/A
  • EPS Growth
  • CAN N/A
  • LXRX N/A
  • EPS
  • CAN N/A
  • LXRX N/A
  • Revenue
  • CAN $317,009,000.00
  • LXRX $31,213,000.00
  • Revenue This Year
  • CAN $115.67
  • LXRX N/A
  • Revenue Next Year
  • CAN $63.75
  • LXRX N/A
  • P/E Ratio
  • CAN N/A
  • LXRX N/A
  • Revenue Growth
  • CAN 65.68
  • LXRX 1251.21
  • 52 Week Low
  • CAN $0.53
  • LXRX $0.28
  • 52 Week High
  • CAN $3.27
  • LXRX $2.25
  • Technical
  • Relative Strength Index (RSI)
  • CAN 42.69
  • LXRX 52.30
  • Support Level
  • CAN $0.65
  • LXRX $1.00
  • Resistance Level
  • CAN $0.71
  • LXRX $1.11
  • Average True Range (ATR)
  • CAN 0.09
  • LXRX 0.10
  • MACD
  • CAN -0.03
  • LXRX -0.03
  • Stochastic Oscillator
  • CAN 7.64
  • LXRX 16.28

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: